5/9/2025

Tracey Ryniec, Zacks Senior Stock Strategist, and Bryan Hayes, editor of Zacks Income Investor newsletter, discuss 5 popular stocks with high dividend yields. Can the dividend be trusted?

Source: Yahoo

5/9/2025

Infant hospitalizations due to respiratory syncytial virus infections in the United States dropped as much as 43% last year compared to previous years, following the widespread availability of...

Source: Finnhub

5/9/2025

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Source: Yahoo

5/9/2025

We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discusses. During a recent episode of Mad Money, which aired on Monday, the 5th of May, Jim Cramer gave some […]

Source: Yahoo

5/9/2025

The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.

Source: Yahoo

5/9/2025

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR stock is a hold.

Source: SeekingAlpha

5/9/2025

BDCs, REITs, MLPs & CEFs offer yield, but fall short on growth and diversification. Read about 2 picks that tackle both for income-focused investors.

Source: SeekingAlpha

5/9/2025

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S. and internationally. If You Bought Pfizer Stock 10 Years Ago The company's stock traded at approximately $31.75 per share ...

Source: Yahoo

5/8/2025

Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.

Source: Yahoo

5/8/2025

Hartford Equity Income Fund (I Share) outperformed the Russell 1000 Value Index during the quarter. Read more here.

Source: SeekingAlpha

5/8/2025

The mean of analysts' price targets for Pfizer (PFE) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Source: Yahoo

5/8/2025

If you invested $54,000 into stocks averaging that kind of a yield, you'd collect just $756 in annual dividend income. The best part is that you're not taking on significant risk with these investments, either. Realty Income (NYSE: O), Pfizer (NYSE: PFE), and Target (NYSE: TGT) are all blue chip stocks that you can hang on for the long haul.

Source: Yahoo

5/8/2025

The Dividend Harvesting Portfolio gained 1.98% this week, with a total return of 23.42%. Find out how the portfolio is well-positioned for future rate cuts.

Source: SeekingAlpha

5/8/2025

With another rare disease approval under its belt, Alnylam is still revving up the R&D engines for new indications.

Source: Yahoo

5/8/2025

Discover the top 10 ReFa/Ro investments with impressive net gains, dividend yields, and target price upsides.

Source: SeekingAlpha

5/8/2025

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what justifies INRLF stock a Buy.

Source: SeekingAlpha

5/7/2025

The U.S. Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients. This change builds upon the agency’s Office of Inspection and Investigations’ Foreign Unannounced Inspection Pilot program in India and China and aims to ensure that foreign companies will receive the same level of regulatory oversight and

Source: Yahoo

5/7/2025

We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the […]

Source: Yahoo

5/7/2025

The U.S. Food and Drug Administrationsaid on Wednesday it will hold a meeting of experts on May 22 todiscuss COVID-19 vaccine recommendations for the upcomingimmunization campaign. ...

Source: Finnhub

5/7/2025

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

Source: MarketWatch